[Form 4] Insmed, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Insider Trade Summary
Net Seller: 57,764 shares ($5,537,460)
Net Sell
10 txns
Insider
Bonstein Sara
Role
Chief Financial Officer
Sold
57,764 shs ($5.54M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 6,244 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 4,362 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 23,565 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 13,717 | $0.00 | -- |
| Exercise | Common Stock | 6,244 | $19.74 | $123K |
| Exercise | Common Stock | 4,362 | $24.70 | $108K |
| Exercise | Common Stock | 23,565 | $26.43 | $623K |
| Exercise | Common Stock | 13,717 | $26.46 | $363K |
| Sale | Common Stock | 35,583 | $95.66 | $3.40M |
| Sale | Common Stock | 22,181 | $96.19 | $2.13M |
Holdings After Transaction:
Stock Option (right to buy) — 18,880 shares (Direct);
Common Stock — 100,137 shares (Direct)
Footnotes (1)
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan. This is the weighted average sales price representing 35,583 shares sold at prices ranging from $95.01 to $96.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. This is the weighted average sales price representing 22,181 shares sold at prices ranging from $96.01 to $96.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
